Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Government Contract opportunity from Department Of Health And Human Services was posted on May 21, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Regulatory Consulting and FDA Submission Support

Closed
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541611
New
SLED
OPERATIONAL EFFICIENCY ASSESSMENT
Solicitation # 26-908
The City of Augusta, Georgia, is seeking proposals under RFP 26-908 for a qualified firm to conduct a comprehensive Operational Efficiency Assessment. The primary objective of this study is to identify opportunities to improve service delivery, reduce or avoid costs, strengthen internal controls, and align staffing and technology with industry best practices. The selected consultant will perform data analysis, structural reviews of organizational spans of control, and business practice assessments across citywide functions and specific departments. Deliverables include a Project Management Plan within 45 to 90 days of the Notice to Proceed, interim updates every 30 days, written summaries of findings per phase, and a final comprehensive report featuring an implementation plan. Proposals must be submitted by October 19, 2026, in two separately sealed envelopes containing technical qualifications and a cost proposal, along with a digital copy on a USB drive. Evaluation is based on a 120-point scale covering firm experience, qualifications, project understanding, management, references, and cost, with an optional interview for short-listed firms. The contract requires the consultant to be legally registered in Georgia and maintain specific insurance coverages, including commercial general, automobile, and umbrella liability. Compliance with E-Verify and the SAVE program is mandatory, and the city emphasizes the participation of local small businesses. Payment is structured as monthly in arrears with net 30-day terms following the city's acceptance of delivered services.
City of Augusta

POSTED

1 day ago

DEADLINE

in about 1 month

AI Contract Overview

Show more

The contract involves providing strategic regulatory planning and submission support services specifically tailored for New Drug Application (NDA), supplemental New Drug Application (sNDA), or Biologics License Application (BLA) filings related to antifungal medical countermeasures. The focus is on guiding and assisting with the complex regulatory requirements necessary for successful FDA submissions in this specialized medical field. Issued by the Department of Health and Human Services under the BARDA division, the opportunity is classified under NAICS code 541611, which pertains to administrative management and general consulting services. It is structured as a subcontract, with the response deadline set for June 21, 2026. Performance location details are not specified, and there is no indication of set-aside status. The contract aims to leverage expert regulatory consulting to facilitate the development and approval of critical antifungal therapies intended for medical countermeasure use.

General Info

Strategic regulatory consulting for NDA, sNDA, BLA antifungal filings under BARDA, deadline June 21, 2026.

Agency

Department Of Health And Human Services → Barda - Aspr / Daappo / Barda DcmaView Agency

NAICS

541611 - Administrative Management and General Management Consulting ServicesView NAICS

Place of Performance

DC, USA

Set-Aside

NONE

Documents

This scope was carved out of RFI-MCM-TDRFI-BARDA-2026.

The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

RFI - Medical Countermeasures for the Treatment of Drug-Resistant Fungal Infections

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PhaseClosed
Posted

subcontract

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Strategic regulatory planning and submission support for NDA, sNDA, or BLA filings related to antifungal medical countermeasures.

More opportunities from Department Of Health And Human Services → Barda - Aspr / Daappo / Barda Dcma

Same awarding agency

NAICS: 541714
New
Federal
Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response
Solicitation # 75A50126R00001_RFP_NPIVS_27
The Biomedical Advanced Research and Development Authority (BARDA) is soliciting proposals for the Vaccine Medical Countermeasures (MCMs) for Pandemic Influenza Preparedness and Response Program. The primary objective is to maintain a permanent readiness posture and a commercially sustainable warm-base production capacity for the rapid manufacture of vaccines, antigens, and adjuvants during public health emergencies. Contractors are required to produce these countermeasures against influenza and other viruses with pandemic potential, generate and submit all necessary analytical, nonclinical, clinical, and chemistry, manufacturing, and controls data to the FDA, and support rapid regulatory decisions. To be eligible, offerors must hold a U.S. influenza vaccine license or have developed an influenza vaccine as evidenced by a Biologics License Application submission. The contract is structured as an IDIQ with a five-year base period and a potential five-year option period, totaling a possible 120-month ordering period. Award decisions will be based on the Highest Technically Rated Offerors with a Fair and Reasonable Price methodology, with a significant emphasis on capabilities. Key requirements include strict adherence to CGMP guidelines, the implementation of comprehensive business and supply continuity plans, and the submission of surge manufacturing and supply chain readiness assessments. Deliverables include the preparation of candidate vaccine viruses and the management of complex logistics, including temperature-controlled shipping and specific packaging standards. Payment is processed quarterly via the Department of Treasury Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

1 day ago

DEADLINE

in 2 months
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS